ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study

Completed · Early Phase 1

Conditions studied: Ovarian Cancer, Adnexal Mass

In brief

The purpose of this study is to find out how well ovarian sentinel lymph nodes (SLNs) can be identified with indocyanine green (ICG) dye during risk-reducing ovarian surgery.

Key facts

Study ID
NCT04051502
Run by
Memorial Sloan Kettering Cancer Center
People needed
48
Starts
2019-08-05
Expected to finish
2025-12-08
Last updated by the study team
2025-12-17

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.